Robotic technology developer Hansen Medical has received U.S. Food and Drug Administration (FDA) clearance for its next-generation Sensei X robotic catheter system.
The Mountain View, CA-based company also has introduced its new Artisan Extend control catheter and Lynx robotic ablation catheter, a small, flexible irrigated ablation catheter for customers in Europe.
The new Sensei X platform is designed to enhance catheter control within the heart during electrophysiology procedures and to help reduce radiation exposure to both the patient and physician.
The Sensei X platform also supports Hansen Medical's CoHesion 3D visualization module, which integrates the 3D motion control of the Sensei X system with the 3D visualization of the EnSite system from St. Jude Medical of St. Paul, MN.
The new Lynx robotic ablation catheter, which the company plans to launch in the European market, is supported by the Sensei X platform and leverages the navigation capability of the Artisan Extend catheter, but in a smaller and more flexible integrated profile for treating atrial fibrillation and other electrophysiology disorders.
Related Reading
GE and Hansen ink angio deal, May 7, 2009
Hansen takes stake in cardiac therapeutic firm, March 3, 2009
Philips, Hansen team up, January 14, 2009
Hansen posts higher Q2 sales, net loss, August 1, 2008
Hansen gets FDA nod for CoHesion, July 2, 2008
Copyright © 2009 AuntMinnie.com
